Skip to main content
Top
Published in: Journal of Neurology 9/2016

01-09-2016 | Original Communication

Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue

Authors: Laura Nastasi, Giovanni Mostile, Alessandra Nicoletti, Mario Zappia, Ester Reggio, Santiago Catania

Published in: Journal of Neurology | Issue 9/2016

Login to get access

Abstract

The purpose of this study was to investigate the impact of botulinum toxin (BoNT) treatment on the quality of life (QoL) for patients with prominent lingual dystonia (LD) using a disease-specific questionnaire, the oromandibular dystonia questionnaire-25 (OMDQ-25). This is a prospective, observational study of a cohort of 30 patients treated with BoNT injections for LD, with or without concurrent jaw dystonia. Primary efficacy outcome was the absolute difference between total OMDQ-25 baseline score and total OMDQ-25 scores 4 and 8 weeks after the treatment. Safety outcome was the occurrence of adverse effects. The mean total OMDQ-25 baseline score was 46.8 ± 17.8. After BoNT treatment, there was a significant reduction in the mean total OMDQ-25 score at 4 weeks (38.2 ± 17.6; p = 0.004), as well as at 8 weeks (39.6 ± 18.1; p = 0.008). At the multiple regression analysis, a jaw deviation pattern (JDD) and high questionnaire baseline total score were detected as predictors of a better outcome, whilst associated jaw tremor was a predictor of poor outcome. In patients with JDD, jaw-opening muscles were more frequently injected and genioglossus less frequently than in patients without JDD. No major adverse events were detected. A consistent and measurable improvement in QoL, with good safety and tolerability, can be achieved in patients with prominent LD by injecting BoNT into genioglossus and/or other muscles of the oromandibular region.
Literature
1.
go back to reference Esper CD, Freeman A, Factor SA (2010) Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy. Parkinsonism Relat Disord 16(7):438–441CrossRefPubMed Esper CD, Freeman A, Factor SA (2010) Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy. Parkinsonism Relat Disord 16(7):438–441CrossRefPubMed
2.
go back to reference Termsarasa P, Tanenbaum DR, Frucht SJ (2014) The phenomenology and natural history of idiopathic lower cranial dystonia. J Clin Mov Disord 1:3CrossRef Termsarasa P, Tanenbaum DR, Frucht SJ (2014) The phenomenology and natural history of idiopathic lower cranial dystonia. J Clin Mov Disord 1:3CrossRef
3.
go back to reference Keane JR (1984) Galloping tongue: post-traumatic, episodic, rhythmic movements. Neurology 34(2):251–252CrossRefPubMed Keane JR (1984) Galloping tongue: post-traumatic, episodic, rhythmic movements. Neurology 34(2):251–252CrossRefPubMed
6.
go back to reference Bader B, Ruth H, Walker MB et al (2010) Tongue protrusion and feeding dystonia: a hallmark of chorea-acanthocytosis. Mov Disord 25(1):127–129CrossRefPubMed Bader B, Ruth H, Walker MB et al (2010) Tongue protrusion and feeding dystonia: a hallmark of chorea-acanthocytosis. Mov Disord 25(1):127–129CrossRefPubMed
7.
go back to reference GollompSM Fahn S (1987) Transient dystonia as a complication of varicella. J Neurol Neurosurg Psychiatry 50(9):1228–1229CrossRef GollompSM Fahn S (1987) Transient dystonia as a complication of varicella. J Neurol Neurosurg Psychiatry 50(9):1228–1229CrossRef
8.
go back to reference Degirmenci Y, OrsCH Yilmaz Y, Karaman HI (2011) Isolated lingual dystonia induced by speaking: a rare form of focal dystonia. Acta Neurol Belg 111(4):360–361PubMed Degirmenci Y, OrsCH Yilmaz Y, Karaman HI (2011) Isolated lingual dystonia induced by speaking: a rare form of focal dystonia. Acta Neurol Belg 111(4):360–361PubMed
9.
go back to reference Ozen B, Gunal DI, Turkmen C, Agan K, Elmaci NT (2011) Speech-induced primary lingual dystonia: a rare focal dystonia. Neurol Sci 32(1):155–157CrossRefPubMed Ozen B, Gunal DI, Turkmen C, Agan K, Elmaci NT (2011) Speech-induced primary lingual dystonia: a rare focal dystonia. Neurol Sci 32(1):155–157CrossRefPubMed
11.
go back to reference Schneider SA, Aggarwal A, Bhatt M et al (2006) Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology 67(6):940–943CrossRefPubMed Schneider SA, Aggarwal A, Bhatt M et al (2006) Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology 67(6):940–943CrossRefPubMed
12.
go back to reference Blitzer A, Brin MF, Fahn S (1991) Botulinum toxin injections for lingual dystonia. Laryngoscope 101(7 Pt 1):799CrossRefPubMed Blitzer A, Brin MF, Fahn S (1991) Botulinum toxin injections for lingual dystonia. Laryngoscope 101(7 Pt 1):799CrossRefPubMed
13.
go back to reference Charles PD, Davis TL, Shannon KM, Hook MA, Warner JS (1997) Tongue protrusion dystonia: treatment with botulinum toxin. South Med J 90(5):522–525CrossRefPubMed Charles PD, Davis TL, Shannon KM, Hook MA, Warner JS (1997) Tongue protrusion dystonia: treatment with botulinum toxin. South Med J 90(5):522–525CrossRefPubMed
14.
go back to reference Hennings JM, Krause E, Bötzel K, Wetter TC (2008) Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature. Prog Neuropsychopharmacol Biol Psychiatry 32(5):1167–1171CrossRefPubMed Hennings JM, Krause E, Bötzel K, Wetter TC (2008) Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature. Prog Neuropsychopharmacol Biol Psychiatry 32(5):1167–1171CrossRefPubMed
15.
go back to reference Kasravi N, Jog MS (2009) Botulinum toxin in the treatment of lingual movement disorders. Mov Disord 24(15):2199–2202CrossRefPubMed Kasravi N, Jog MS (2009) Botulinum toxin in the treatment of lingual movement disorders. Mov Disord 24(15):2199–2202CrossRefPubMed
16.
go back to reference Rosales RL et al (2011) The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A [Dysport(R)] injections for oromandibular, lingual, and truncal-axial dystonias. Int J Neurosci 121(Suppl 1):44–56CrossRefPubMed Rosales RL et al (2011) The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A [Dysport(R)] injections for oromandibular, lingual, and truncal-axial dystonias. Int J Neurosci 121(Suppl 1):44–56CrossRefPubMed
17.
go back to reference Hallett M, Benecke R, Blitzer A, Comella CL (2009) Treatment of focal dystonias with botulinum neurotoxin. Toxicon 54(5):628–633CrossRefPubMed Hallett M, Benecke R, Blitzer A, Comella CL (2009) Treatment of focal dystonias with botulinum neurotoxin. Toxicon 54(5):628–633CrossRefPubMed
18.
go back to reference Kanovsky P, Streitová H, Bares M, Hortová H (1999) Treatment of facial and orolinguomandibular tardive dystonia by botulinum toxin A: evidence of a long-lasting effect. Mov Disord 14(5):886–888 Kanovsky P, Streitová H, Bares M, Hortová H (1999) Treatment of facial and orolinguomandibular tardive dystonia by botulinum toxin A: evidence of a long-lasting effect. Mov Disord 14(5):886–888
19.
go back to reference Merz RI, Deakin J, Hawthorne MR (2010) Oromandibular dystonia questionnaire (OMDQ-25): a valid and reliable instrument for measuring health-related quality of life. Clin Otolaryngol 35(5):390–396CrossRefPubMed Merz RI, Deakin J, Hawthorne MR (2010) Oromandibular dystonia questionnaire (OMDQ-25): a valid and reliable instrument for measuring health-related quality of life. Clin Otolaryngol 35(5):390–396CrossRefPubMed
20.
go back to reference Ravenni R, De Grandis D, Mazza A (2013) Conversion ratio between Dysport and Botox in clinical practice: an overview of available evidence. Neurol Sci 34(7):1043–1048CrossRefPubMed Ravenni R, De Grandis D, Mazza A (2013) Conversion ratio between Dysport and Botox in clinical practice: an overview of available evidence. Neurol Sci 34(7):1043–1048CrossRefPubMed
21.
go back to reference Sato K, Awad ZT, Filipi CJ et al (2002) Causes of long-term dysphagia after laparoscopic Nissen fundoplication. JSLS 6(1):35–40PubMedPubMedCentral Sato K, Awad ZT, Filipi CJ et al (2002) Causes of long-term dysphagia after laparoscopic Nissen fundoplication. JSLS 6(1):35–40PubMedPubMedCentral
23.
go back to reference Bhattacharyya N, Tarsy D (2001) Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia. Arch Otolaryngol Head Neck Surg 127(4):389–392CrossRefPubMed Bhattacharyya N, Tarsy D (2001) Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia. Arch Otolaryngol Head Neck Surg 127(4):389–392CrossRefPubMed
24.
go back to reference Tarsy D, Si Ro (2006) Unusual position-sensitive jaw tremor responsive to botulinum toxin. Mov Disord 21(2):277–2788CrossRefPubMed Tarsy D, Si Ro (2006) Unusual position-sensitive jaw tremor responsive to botulinum toxin. Mov Disord 21(2):277–2788CrossRefPubMed
25.
go back to reference Gonzalez-Alegre P, Kelkar P, Rodnitzky RL (2006) Isolated high-frequency jaw tremor relieved by botulinum toxin injections. Mov Disord 21(7):1049–1050CrossRefPubMed Gonzalez-Alegre P, Kelkar P, Rodnitzky RL (2006) Isolated high-frequency jaw tremor relieved by botulinum toxin injections. Mov Disord 21(7):1049–1050CrossRefPubMed
26.
go back to reference Yasufuku-Takano J, Sakurai M, Kanazawa I, Nagaoka M (1995) Successful treatment of intractable tardive dyskinesia with botulinum toxin. J Neurol Neurosurg Psychiatry 58(4):511–512CrossRefPubMedPubMedCentral Yasufuku-Takano J, Sakurai M, Kanazawa I, Nagaoka M (1995) Successful treatment of intractable tardive dyskinesia with botulinum toxin. J Neurol Neurosurg Psychiatry 58(4):511–512CrossRefPubMedPubMedCentral
Metadata
Title
Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue
Authors
Laura Nastasi
Giovanni Mostile
Alessandra Nicoletti
Mario Zappia
Ester Reggio
Santiago Catania
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 9/2016
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-016-8185-1

Other articles of this Issue 9/2016

Journal of Neurology 9/2016 Go to the issue